Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2019, Article ID 7151685, 19 pages
https://doi.org/10.1155/2019/7151685
Review Article

Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use

Director, Clinical Research; Consultants in Neurology, Multiple Sclerosis Center, Northbrook, IL, USA

Correspondence should be addressed to Daniel R. Wynn; moc.liamg@dmnnywd

Received 9 January 2018; Revised 29 June 2018; Accepted 29 November 2018; Published 15 January 2019

Academic Editor: Bruno Brochet

Copyright © 2019 Daniel R. Wynn. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Daniel R. Wynn, “Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use,” Multiple Sclerosis International, vol. 2019, Article ID 7151685, 19 pages, 2019. https://doi.org/10.1155/2019/7151685.